Disclaimer:  The following information is drawn from materials prepared by candidates for promotion to full professor.  It is intended to illustrate activities and materials that might support promotion.  In using these materials, please note the following:

               *The Provost (and, in some cases, the President) are the University officers authorized to approve promotions.  All levels of review below these officers are advisory.

               *Only Departments are empowered to propose promotions, and the Divisional Dean is charged with transmitting such proposals to the Provost or returning them to the Department.

*The judgment of the Department, Dean, and Provost will therefore be critical to assessing qualification for promotion.

               *Materials considered by the Department, Dean, and Provost will also (and always) include confidential evaluations obtained from outside the University.  Materials considered by the Provost will include the confidential evaluations of the Dean and Department, and those considered by the Dean will include the confidential evaluations of the Department.

               *Thus, the following materials are ONLY PART of a complete proposal for promotion, whereas promotion is based on the ENTIRE proposal.   Therefore, it should not be assumed that a record comparable to that below will necessarily result in promotion, or that a record not comparable to that below will fail to result in promotion.  The Departmental Chair is likely to be the best source of advice as to whether promotion is feasible and, when it is not, what additional activity may result in qualification for promotion.

               *This document has been prepared as a tool for use by associate professors in the Division of the Biological Sciences.  Other individuals who may find it informative are Department Chairmen, Section Heads, Committee Chairmen, senior faculty and potential recruits.  Its intent is to help guide individuals and their departments as they think about promotion to Professor.  This document is not intended to list the elements that every promotion proposal will be expected to address.  The following information is presented for information purposes only and is not intended to create any contract or agreement, and its contents are subject to addition, deletion, and change without prior notice.

Name:

Elaine M. Worcester, M.D.

 

 

Department of Primary Appointment:

Medicine

 

Present rank:

Associate Professor

 

Present track:

Clinician-Educator

 

Proposed rank:

PROFESSOR

 

Proposed track:

CLINICIAN-EDUCATOR

DEPARTMENT: What is the candidate's field or specialization within medicine

Pathophysiology, evaluation and management of kidney stones

LAY SUMMARY:

Clinical: Dr. Worcester was the medical director of the hospital-owned Lake Park Hemodialysis Unit from September 2000 until June 2006, responsible for the care of the 110-120 patients receiving their dialysis treatments there. She provided all direct medical care for the patients until joined by Dr. Bharathi Reddy in July 2003, who assumed direct care for half the patients. The medical director is also responsible for oversight of care by all practitioners at the unit, and compliance with CMS guidelines, including regular review of standing orders, care plans, vaccination status, infection control, and dialyzer reuse.  Dr. Worcester has had approximately 8 weeks per year of responsibility for Nephrology inpatient services, including both the dialysis and consult services. In addition, she has one half day outpatient clinic each week. In July 2003, she joined Drs. Fredric Coe and John Asplin as a part of the Kidney Stone Program, and sees both kidney stone and general nephrology outpatients.

 

Educational: Dr. Worcester has supervised nephrology fellows during their rotations in the dialysis units, where first year fellows spend 2 months, and second year fellows care for a shift of patients for the entire year, and teaches fellows and residents rotating on the Nephrology inpatient services. She gives lectures as part of the Nephrology FellowÕs lecture series and also the Nephrology portion of the Clinical Pathophysiology course for second year medical students. She is director of the Essentials of Patient-Oriented Research Course, a weekly lecture series during the fall, winter and spring quarters, which is a part of the K30 Clinical Research Training Program.

 

Administrative: Dr. Worcester was director of Chronic Hemodialysis from July 2001-June 2006, overseeing the three outpatient hemodialysis units owned by the University, which care for about 400 patients. She is currently Clinical Director of the Kidney Stone Evaluation Laboratory, a CAP-approved lab located within the Nephrology Section.

 

Research: Dr. Worcester is involved in clinical research on the pathophysiology of kidney stones. This includes an on-going General Clinical Research Center (GCRC) protocol investigating mineral excretion in hypercalciuric stone formers, analysis of clinical data accumulated over the 30 years of the Kidney Stone Program, and development of a new rodent model of stone formation.

CURRICULUM VITAE

 

Society Memberships:

               1984-present   International Society of Nephrology

               1984-present   American Society of Nephrology

                                    Session Organizer and Co-chair, Annual Scientific Meetings 2000, 2004

                                    Abstract Reviewer, Annual Scientific Meetings 2003, 2005 

               1986-present   National Kidney Foundation

               1992-1994       American Federation for Clinical Research;                          

                                    Council Member, Midwest Section

               2001-present   Renal Physicians Association

               2001-2006       National Renal Administrators Association 

               1990--present ROCK (Research on Calculus Kinetics) Society  (elected)

               2003-present   Women in Nephrology

               2006-present   American Physiological Society

                                            

Community Advisory Committees and/or Activities:

1991-95            Board Member, National Kidney Foundation of WI

1991-92            Vice President, Milwaukee Chapter, National Kidney Foundation of WI

1992-93            President, Milwaukee Chapter, National Kidney Foundation of WI

1993-96            Member, Affiliate Board of Directors, National Kidney Foundation of WI

2002-2005       Member, Medical Review Board, End Stage Renal Disease Network 9 &                                     10 (elected). The Renal Networks, under the direction of CMS, are                                                responsible for overseeing the quality of care and access                                                                to services of ESRD patients in their region. Network 9/10 serves                                                 Illinois, Indiana, Ohio, and Kentucky.

 

National Committees and Study Sections:

1/1993            ÒPrevention and Dissolution of Renal StonesÓ. NIH Ad Hoc Review Committee, Washington, D.C.

2/1993             NIH Site Visit Review Committee, Program Project Grant, University of Texas Southwestern Medical Center, Dallas, Texas.

2/1996               Member, Special Review Committee, National Institute of Diabetes and Digestive and Kidney Diseases

10/2000             Session Organizer and Co-Chair: ÒNephrolithiasis: Key Pathogenetic and Clinical Issues in 2000Ó, American Society of Nephrology, Toronto

2003                American Society of Nephrology Annual Meeting Abstract Reviewer, Stone Disease

12/2003             Invited participant, Conference on the Medical Evaluation of the Living Renal Donor, Dallas, TX.

10/2004             Session Organizer and Co-Chair: ÒCell Biology of NephrolithiasisÓ, American Society of Nephrology, St. Louis, MO.

2005                American Society of Nephrology Annual Meeting Abstract Reviewer, Stone Disease

3/2006                           Member of Planning Committee and Invited Speaker for NIH Urolithiasis Workshop, March 9-10, 2006, Baltimore, MD.

                         This meeting was organized to bring together the leading investigators in the field of urolithiasis research, in order to produce recommendations about the most important areas for future research.

6/26/2006         Invited Member, NIH Urology and Kidney Development and Genitourinary Diseases Study Section, Renal and Urological Studies Review Group

2006-present   Data and Safety Monitoring Board, STONE Study, National Institute of Diabetes and Digestive and Kidney Diseases, NIH

10/2006             Invited Member, NIH Renal and Urological Studies Scientific Review Group

2/13/2007        Invited Member, NIH Urology and Kidney Development and Genitourinary Diseases Study Section, Renal and Urological Studies Review Group

             

Editorial: 

Reviewer for:

Kidney International

American Journal of Physiology (Renal, Fluid and Electrolyte Physiology)

Journal of Urology

Journal of the American Society of Nephrology

Clinical and Experimental Hypertension

International Society for the Study of Hypertension in Pregnancy

Calcified Tissue International

Clinical Chemistry

Urological Research

 

Contributor – UpToDate in Nephrology       2006-

Ad hoc reviewer – The Oxalosis and Hyperoxaluria Foundation    2004, 2006

       

PRESENTATIONS

Invited Lectures:

7/87      ÒGlycoprotein Inhibitors of Calcium Oxalate Stone FormationÓ. Presented at the 10thInternational Congress of Nephrology, London, UK.

8/88      ÒRenal Calculi: Diagnosis and TherapyÓ and ÒAbnormalities of Divalent Ion MetabolismÓ. Eighth Comprehensive Nephrology Review Course, UCLA Extension, Santa Monica, CA.

8/89      ÒRenal Calculi: Evaluation and ManagementÓ. Medical Case Conference, St. JosephÕs Hospital, Milwaukee, WI.

1/92      ÒAdvances in the Understanding of Crystal Formation Inhibitors in the UrineÓ Grand Rounds, Waukesha Memorial Hospital, Waukesha, WI.

3/92      ÒProgression of Renal Disease: Diet and HypertensionÓ. Invited speaker, American Nephrology Nurses Association, Green Bay, WI.

3/92      ÒManagement of Kidney Stone DiseaseÓ. Invited panelist, American College of Physicians Annual Session, San Diego, CA.

4/93      ÒManagement of Kidney Stone DiseaseÓ. Invited Panelist, American College of Physicians Annual Session, Washington, D.C..

8/93      ÒKidney Stones: An Ounce of PreventionÓ. Grand Rounds, Columbia Hospital, Milwaukee, WI.

4/94      ÒUrinary Calcium Oxalate Crystal Growth InhibitorsÓ. Presented at the Jacob Lemann, Jr. M.D. Scientific Symposium & Fetschrift, Froedert Memorial Lutheran Hospital, Milwaukee, WI.

9/94      ÒRenal Stones: Causes and PreventionÓ. Invited speaker, Memorial Hospital Clinical Symposium, Woodstock, IL.

10/94   ÒOsteopontin Production by Cultured Kidney CellsÓ. Invited speaker at the New York Academy of Sciences Conference. ÒOsteopontin; Role in Cell Signaling and AdhesionÓ, New Brunswick, NJ.

10/94   ÒCurrent Treatment of Hypercalcemia and Disorders of Divalent IonsÓ. Invited panelist, The American Society of Nephrology Annual Scientific Meeting, ÒShort Courses in the Clinical Practice of NephrologyÓ, Orlando, FL.

10/95   ÒIs a Metabolic Stone Evaluation Needed in the Age of ESWL?Ó. Invited speaker, American Lithotripsy Society Meeting, San Antonio, TX.

10/95   ÒHistory of Inhibitors in Stone DiseaseÓ. Visiting Professor, Ohio State University, Columbus, Ohio.

10/95     ÒUrologic Stones and Bowel DiseaseÓ. Visiting Professor, Ohio State University, Columbus, Ohio.

7/96      ÒEvaluation of Patients with NephrolithiasisÓ. Waukesha Memorial Hospital, Waukesha, WI, Allstaff Conference.

3/97        ÒPrevention of Kidney StonesÓ. St. MaryÕs Hospital, Milwaukee, WI.

4/97        ÒRenal FailureÓ. Elmbrook Memorial Hospital, Brookfield, WI, April 1997.

10/97     ÒPrevention of Acute Renal FailureÓ. Nephrology for the Primary Care Physician. Waukesha Memorial Hospital, Waukesha, WI.

10/98     ÒHypernatremia and Hyponatremia – Diagnosis and ManagementÓ. Nephrology for the Primary Care Physician, Waukesha Memorial Hospital, Waukesha, WI.

11/99     ÒChronic Renal Failure: Preventing Progression and Preparing for the WorstÓ. Allstaff Conference, Waukesha Memorial Hospital, Waukesha, WI.

1/30/01   ÒA Patient with ProteinuriaÓ.  Medicine Grand Rounds, Univ. of Chicago.

4/16/03   ÒKidney StonesÓ. Update in Nephrology, Crystal Lake, IL

9/16/03   ÒHypercalcemia in a Dialysis PatientÓ. Medicine Grand Rounds, Univ. of Chicago.

2/21/04   ÒCalcium oxalate stone formation in a rat model of enteric hyperoxaluria.Ó ROCK Society Annual Meeting, Gainesville, FL.

4/28/04   ÒCareer Choices in NephrologyÓ, National Kidney Foundation Clinical Meeting, Chicago, IL.

6/11/04   ÒContemporary Management of Kidney StonesÓ, Chicago Nephrology Day, Network 9&10 Nephrology Symposium, Chicago, IL.

10/9/04   ÒA new animal model of hyperoxaluriaÓ. Invited speaker, 7th International Workshop on Primary Hyperoxaluria, Mayo Clinic, Rochester, MN.

5/18/05  ÒMetabolic Stone Disease: Diagnosis and ManagementÓ. Invited speaker, Nephrology Symposium, SIU School of Medicine, Springfield, IL.  

6/3/05    ÒVascular Access UpdateÓ.  Women in Nephrology Symposium: New Interventions for Kidney Disease. University of Chicago, Chicago, IL.

3/9/06    ÒObesity, bariatric surgery, and stones.Ó NIH Symposium on Urolithiasis, Baltimore, MD, March 9, 2006.

4/19/06   ÒCareer Choices in NephrologyÓ, National Kidney Foundation Clinical Meeting, Chicago, IL.

11/2/06   ÒChanges in renal function and blood pressure in stone formers.Ó First International Urolithiasis Research Symposium, Indianapolis, IN

1/12/07   ÒA rodent model of enteric hyperoxaluria and stonesÓ Nephrology Research Conference, University of Chicago.

5/12/07   ÒKidney Stones: Current Understanding of an Ancient DiseaseÓ. MenÕs Health Symposium, Munster, IN.

5/22/07   ÒClinical and laboratory characteristics of patients who transform from calcium oxalate to calcium phosphate stone formers.Ó American Urological Society Annual Meeting, Anaheim, CA.

11/07      ÒPathophysiology of Renal Stone DiseaseÓ. American Society of Nephrology Annual Meeting, San Francisco, CA.